Skip to main content

COVID19

  • COVID-19

COVAX

  • COVAX

Country Hub

  • Country Portal

Secondary nav

  • Global Vaccine Summit
  • Ethics Hotline

Donate

  • Donate
  • EN
  • FR
Home

Main navigation

Menu
  • Our Alliance
    Our Alliance
    • About
    • Strategy
      • Phase 5 (2021-2025)
        • The equity goal
        • The healthy markets goal
        • The sustainability goal
        • The vaccine goal
      • Phase 4 (2016-2020)
        • The market shaping goal
        • The sustainability goal
        • The systems goal
        • The vaccine goal
      • Phase 3 (2011-2015)
        • The financing goal
        • The health systems goal
        • The market shaping goal
        • The vaccine goal
      • Phase 2 (2006-2010)
      • Phase 1 (2000-2005)
      • Risk management
      • Vaccine investment strategy
      • Gender and immunisation
    • Operating model
      • Gavi's partnership model
        • The Bill & Melinda Gates Foundation
        • UNICEF
        • WHO
        • The World Bank Group
        • Civil society organisations
        • Developing country governments
        • Developing country pharmaceutical industry
        • Industrialised country governments
        • Industralised country pharmaceutical industry
        • Research and technical institutes
      • Gavi's business model
      • Gavi Secretariat
      • Transparency and IATI
    • Governance
      • Gavi Board
        • Board Committees
        • Board composition
        • Board members
        • Board minutes
        • Calendar
      • Governance and legal structures
      • Corporate Policies
      • Audit and Investigations
    • Market Shaping
      • The Vaccine Innovation Prioritisation Strategy
      • Supply and procurement roadmaps
      • Product information for vaccines and cold chain equipment
      • Vaccine demand forecasting
    • Global Health & Development
      • Decade of vaccine collaboration
      • International Health Partnership for UHC 2030
      • Millennium Development Goals
      • Sustainable Development Goals
      • UN Global Strategy for Women's, Children's and Adolescents' Health
    • Work with us
      • Culture
      • Vacancies
      • Internship programme
      • RFPs and Consulting Opportunities

    @SaveTheChildren / Hanna Adcock

    #VaccinesWork  

    Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

    FOCUS AREAS Gavi@20 Progress report Partners Our Board


    CAREERS Current vacancies Internship programme RFPs and consulting


    Contact us Phishing and fraud

  • Programmes & Impact
    Programmes & Impact
    • How our support works
      • Support guidelines
        • Apply for vaccine support
        • Apply for health system strengthening support
        • Apply for cold chain equipment support
        • Report on and renew existing Gavi support
        • Access targeted country assistance
        • Additional support guidance documentation
      • Independent Review Committee
      • Joint appraisals
      • Grant performance frameworks
      • Country portal
    • Types of support
      • Vaccine support
        • Human papillomavirus
        • Inactivated polio vaccine
        • Japanese encephalitis
        • Measles and measles-rubella
        • Meningitis A
        • Oral cholera
        • Pentavalent
        • Pneumococcal
        • Rotavirus
        • Typhoid
        • Yellow fever
      • Health system and immunisation strengthening
        • Immunisation supply chain
        • Data
        • Leadership, management and coordination
        • Demand promotion
      • Partners' engagement framework
        • Targeted country assistance
        • Strategic focus areas
        • Foundational support
      • Making immunisation sustainable
        • Eligibility
        • Transitioning out of Gavi support
        • Co-financing
      • Civil society organisation
    • Country Hub
      • Africa
        • Angola
        • Benin
        • Burkina Faso
        • Burundi
        • Cameroon
        • Central African Republic (the)
        • Chad
        • Comoros
        • Congo
        • Congo, DR
        • Côte d’Ivoire
        • Eritrea
        • Ethiopia
        • Gambia
        • Ghana
        • Guinea
        • Guinea-Bissau
        • Kenya
        • Lesotho
        • Liberia
        • Madagascar
        • Malawi
        • Mali
        • Mauritania
        • Mozambique
        • Niger
        • Nigeria
        • Rwanda
        • Sao Tome and Principe
        • Senegal
        • Sierra Leone
        • South Sudan
        • Tanzania, UR
        • Togo
        • Uganda
        • Zambia
        • Zimbabwe
      • Americas
        • Cuba
        • Haiti
        • Honduras
        • Nicaragua
        • Bolivia
        • Guyana
      • Eastern Mediterranean
        • Afghanistan
        • Djibouti
        • Pakistan
        • Somalia
        • Sudan
        • Yemen
      • Europe
        • Albania
        • Armenia
        • Azerbaijan
        • Bosnia & Herzegovina
        • Georgia
        • Kyrgyzstan
        • Moldova
        • Tajikistan
        • Turkmenistan
        • Ukraine
        • Uzbekistan
      • Southeast Asia
        • Bangladesh
        • Bhutan
        • India
        • Indonesia
        • Korea, DPR
        • Myanmar
        • Nepal
        • Sri Lanka
        • Timor Leste
      • Western Pacific
        • Cambodia
        • China
        • Kiribati
        • Lao PDR
        • Mongolia
        • Papua New Guinea
        • Solomon islands
        • Vietnam
    • Our impact
      • Measuring our performance
        • 2011 - 2015 indicators
        • 2016 - 2020 indicators
      • Countries approved for support
      • Disbursements and Commitments
      • Evaluation studies
        • Accelerated Vaccine Introduction project review
        • ADIPs and Hib Initiative Evaluation
        • Baseline study for AMC
        • Co-financing, eligibility and transition policies evaluation 2019
        • Cold Chain Equipment Optimization Platform Evaluation
        • Co-financing Policy Evaluation
        • Evaluation of Gavi support to CSO 2012
        • Evaluation of Gavi support to CSO 2018
        • Evaluation of the drivers of urban immunisation in Uganda; Kampala case study (Phase 1)
        • Full country evaluations
        • Gavi first evaluation report
        • Gavi second evaluation report
        • Gavi support to Albania evaluation
        • Gavi support to Bosnia and Herzegovina evaluation
        • Gavi-Government of China Hepatitis B vaccination programme
        • Gender policy evaluation
        • Gender policy evaluation 2019
        • Health system strengthening evaluations
        • IFFIm evaluation
        • Immunisation services support evaluation
        • Injection safety support evaluation
        • Measles campaigns in Nigeria
        • Mid-Term Evaluation of MoU8
        • Pneumococcal AMC outcomes and impact evaluation
        • Pneumococcal AMC process and design
        • Review of IRCs
        • Technical assistance through the Partners Engagement Framework evaluation
        • Using Geospatial Technologies to improve immunisation coverage and equity
        • Other studies
        • Using digital technologies for real-time supplementary monitoring of immunisation activity
      • Facts and figures
      • Progress reports
    • Programmatic Policies
      • Co-financing policy
      • Eligibility and transitioning
      • Fragility, emergencies and refugees policy
      • Gender policy
      • Health system and immunisation strengthening support framework
      • Prioritisation mechanism
      • Risk policy
      • Self-procurement policy
      • Transparency and accountability
      • Vaccine donation policy

    SUPPORTED COUNTRIESSupported countriesGavi supported a total of 73 countries in 2018
    Explore our Country Hub ->

    FOR COUNTRIES

    Apply for support

    Renew support

     

    OUR RESULTS

    Evaluation studies

    Facts and figures

    Progress reports

  • Investing in Gavi
    Investing in Gavi
    • Resource mobilisation process
      • Global Vaccine Summit 2020
      • Gavi's Investment Opportunity launch meeting, 30 August 2019
      • Gavi Mid-Term Review, Abu Dhabi high level conference, 10-11 December 2018
      • Gavi pledging conference January 2015
      • Gavi replenishment launch meeting May 2014
      • Gavi Mid-Term Review meeting October 2013
      • Gavi pledging conference June 2011
      • Call for Action and Resources October 2010
      • Financing Country Demand March 2010
    • Funding
      • Overview 2000-2037
      • Current period 2016-2020
      • Donor profiles
        • Airtel Nigeria
        • Al Ansari Exchange
        • Alwaleed Philanthropies
        • Audacious Alliance
        • Australia
        • The Bill & Melinda Gates Foundation
        • Brazil
        • Burkina Faso
        • Cameroon
        • Canada
        • The Children’s Investment Fund Foundation (UK)
        • China
        • China Merchants Charitable Foundation
        • Colombia
        • Comic Relief
        • Denmark
        • ELMA Vaccines and Immunization Foundation
        • European Commission
        • Finland
        • France
        • Germany
        • Girl Effect
        • Greece
        • HH Sheikh Mohammed bin Zayed Al Nahyan
        • Iceland
        • India
        • International Federation of Pharmaceutical Wholesalers
        • Ireland
        • Italy
        • Japan
        • Kingdom of Bhutan
        • Kingdom of Saudi Arabia
        • KS Relief
        • "la Caixa" Banking Foundation
        • Laerdal
        • Lions Club International Foundation (LCIF)
        • LDS Charities
        • Luxembourg
        • Mastercard
        • Mauritius
        • The Netherlands
        • New Zealand
        • Niger
        • Norway
        • Orange
        • Other private donors
        • Portugal
        • Principality of Monaco
        • Reckitt Benckiser Group
        • Red Nose Day Fund
        • Reed Hastings and Patty Quillin
        • Republic of Korea
        • Rockefeller Foundation
        • Russian Federation
        • South Africa
        • Spain
        • State of Qatar
        • State of Kuwait
        • Sultanate of Oman
        • Sweden
        • Switzerland
        • TikTok
        • TransferWise
        • Uganda
        • UBA Foundation
        • Unilever
        • United Kingdom
        • United States of America
        • UPS
    • Partnering with business
      • Financial partnerships
      • Leveraged partnerships
      • Operational partnerships
      • Become a partner
    • Innovative financing
      • IFFIm
      • Pneumococcal AMC
        • About the pneumococcal AMC
        • How it works
        • Manufacturers
        • How countries can apply
        • Timeline
        • Independent Assessment Committee
        • AMC legal agreements
      • Gavi Matching Fund
      • Loan buydown
    • INFUSE
      • INFUSE community
      • Call for innovations

    GLOBAL VACCINE SUMMIT

    World leaders make historic commitments to provide equal access to vaccines for all

    KEY AREAS

    Donor profiles

    Matching Fund

    Pneumococcal AMC

  • #VaccinesWork
    #VaccinesWork
    • COVID-19
    • Country stories
    • Photo stories
    • Videos
    • Opinions
    • Value of vaccination
      • Added value
      • Cost-effective
      • Health equity
      • Tried and tested

    FEATURED STORY

    Gavi/2020/Benedikt v.Loebell.

    COVAX explained

    Read more

  • News & Resources
    News & Resources
    • Media room
      • News releases
      • Media contacts
      • Leadership biographies
    • Audio-visual
      • Videos
      • Galleries
      • Infographics
      • Presentations
    • Publications
    • Document library
      • COVID-19 situation reports
      • Evaluations
      • IRC reports
      • Financial reports

    KEY PUBLICATION

    Gavi innovation catalogue

     

    PROGRESS REPORT

    Download the 2019 Gavi progress report

  • EN
  • FR
  • Home
  • News and resources
  • Media room
  • News releases
Back to

News releases

Access all of the press releases and statements related to the work of the Vaccine Alliance

Gavi/Ghana/Olivier Asselin

Access all of the press releases and statements related to the work of the Vaccine Alliance

5 February 2020

Global measles vaccination drive to protect up to 45 million children

Introduction in Ethiopia of a second dose of measles-containing vaccine into routine immunisation programmes. Credit: 2019/Gavi/Frédérique Tissandier.
Read more

29 January 2020

Indonesia to protect four million children a year against pneumonia

Students at a junior high school at the launch of Indonesia’s national measles-rubella immunisation campaign. August 2017. Credit: Gavi/2017/Ardiles Rante.
Read more

24 January 2020

Gavi statement following the death of Peter Salama

Dr Peter Salama, WHO Executive Director, Universal Health Coverage, speaking during the 2019 PMNCH Accountability Breakfast. Credit: Mélanie Einzig/2019/Gavi.
Read more

23 January 2020

World leaders commit to Gavi's vision to protect the next generation with vaccines

Angela Merkel, Federal Chancellor of Germany, speaking during her Special Address at WEF 2020. Credit: World Economic Forum/Ciaran McCrickard.
Read more

5 December 2019

Gavi Board appoints Sarah Goulding as Vice Chair

Sarah Goulding
Read more

5 December 2019

Gavi Board approves new Ebola vaccine programme

Dr. Sakoba Keita, coordinator of the Guinean Ebola Response speaks to local media during a village meeting on Ebola. The World Health Organisation ran phase III clinical trials for ebola virus disease vaccine in Guinea. Credit: Gavi/2015/Sean Hawkey.
Read more

22 November 2019

Meet the newest ambassadors for immunisation: 10,000 Karachi schoolgirls

Credit: Gavi/2019/Asad Zaidi.
Read more

21 November 2019

Gavi congratulates the Global Polio Eradication Initiative for raising vital funds to tackle polio

A health worker administers an oral polio vaccination dose to a child in the Kenema District of Sierra Leone. Credit: Gavi/2016/Kate Holt.
Read more

15 November 2019

Pakistan becomes first country to introduce new typhoid vaccine into routine immunisation program

A man with his son during a vaccination session in Punjab Province, Pakistan. Credit: Gavi/2017/Asad Zaidi.
Read more

12 November 2019

New partnership launched to increase uptake of life-saving vaccines in Rwanda

Girl Effect partnership
Read more

12 November 2019

Gavi welcomes European Commission approval of first Ebola vaccine

Health workers prepare the first shots of the Ebola vaccine in Mbandaka, DRC, during the 2018 outbreak. Credit: Gavi/2018/P Barollier.
Read more

5 November 2019

Democratic Republic of Congo launches major push against measles, cholera, and rotavirus

A mother receives a dose of the oral cholera vaccine in North Kivu, Democratic Republic of Congo
Read more

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • Next page Next ›
  • Last page Last »
Last updated: 25 Feb 2021

Subscribe to our newsletter

Home

Footer

  • Our Alliance
  • Programmes & impact
  • Investing in Gavi
  • #VaccinesWork
  • News & resources

Country Hub

  • Country Portal

Donate

  • Donate

Footer nav

  • Careers
  • Contact
  • Ethics hotline
  • IFFIm
  • Privacy Policy
  • Terms of use
  • Phishing and fraud

© Gavi 2020

  • Gavi Facebook
  • Gavi Twitter
  • Gavi LinkedIn

Our achievements are thanks to the support and expertise of our founding partners